Hans-Jochem Kolb

Hans-Jochem Kolb publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hans-Jochem Kolb sits on this spectrum.

Hans-Jochem Kolb D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hans-Jochem Kolb sits on this spectrum.

Best Publications

• Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

  G Socié;J V Stone;J R Wingard;D Weisdorf

  949
  Citations

• Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

  Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger

  913
  Citations

• Graft-versus-leukemia effects of transplantation and donor lymphocytes

  Hans-Jochem Kolb

  810
  Citations

• Sequential Regimen of Chemotherapy, Reduced-Intensity Conditioning for Allogeneic Stem-Cell Transplantation, and Prophylactic Donor Lymphocyte Transfusion in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome

  Christoph Schmid;Michael Schleuning;Georg Ledderose;Johanna Tischer

  563
  Citations

• Graft-versus-leukemia reactions in allogeneic chimeras

  Hans-Jochem Kolb;Hans-Jochem Kolb;Christoph Schmid;Christoph Schmid;A. John Barrett;A. John Barrett;Dolores J. Schendel;Dolores J. Schendel

  538
  Citations

• Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

  Gérard Socié;Claudia Schmoor;Wolfgang A. Bethge;Hellmut D. Ottinger

  388
  Citations

• Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

  Rüdiger Hehlmann;Michael Lauseker;Susanne Saußele;Markus Pfirrmann

  350
  Citations

• The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2

  Andreas Reiter;Christoph Walz;Ann Watmore;Claudia Schoch

  347
  Citations

• Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

  Andreas Moosmann;Iris Bigalke;Johanna Tischer;Leah Schirrmann

  290
  Citations

• Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era : evaluation of its impact within a subgroup of the randomized German CML Study IV

  Susanne Saussele;Michael Lauseker;Alois Gratwohl;Dietrich W. Beelen

  286
  Citations

• Proteomics applied to the clinical follow up of patients after allogeneic hematopoietic stem cell transplantation

  Thorsten Kaiser;Haytham Kamal;Andreas Rank;Hans-Jochem Kolb

  245
  Citations

• Prospective evaluation of neurological complications after allogeneic bone marrow transplantation

  P. Sostak;C.S. Padovan;T.A. Yousry;G. Ledderose

  233
  Citations

• Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

  F van Rhee;R M Szydlo;J Hermans;A Devergie

  224
  Citations

• High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

  Charalampia Kyriakou;Carmen Canals;Anthony Goldstone;Dolores Caballero

  213
  Citations

• Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics.

  Ralf Huss;Claudia Lange;Eva M. Weissinger;Hans-Jochem Kolb

  210
  Citations

• Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change

  Maximilian Christopeit;Oliver Kuss;Jürgen Finke;Ulrike Bacher

  208
  Citations

• Adoptive immunotherapy with donor lymphocyte transfusions.

  Hans-Jochem Kolb;Ernst Holler

  202
  Citations

• Impact of human herpesvirus-6 after haematopoietic stem cell transplantation.

  Marcus Hentrich;Daniel Oruzio;Gundula Jäger;Marcus Schlemmer

  195
  Citations

• Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation

  Christoph Salat;Ernst Holler;Hans-Jochem Kolb;Brigitte Reinhardt

  190
  Citations

• Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT

  D W Milligan;M C Ruiz De Elvira;H J Kolb;A H Goldstone

  179
  Citations